GGrantIndex
Sort

23,748 grants matching melanoma

Immune Monitoring Core

$169,720
Laszlo George Radvanyi · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA

Pesticides And Parkinson s Disease In The Agricultural Health Study

$169,694
Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES

Imaging Infused CD19 Specific T Cells in the Tumor

$169,680
Laurence J.n. Cooper · University Of Tx Md Anderson Can Ctr · R21 · FY2007 · CA

Community Outreach and Engagement

$169,660
Sora Park Tanjasiri · University Of California-Irvine · P30 · FY2022 · CA

Moffitt Cancer Center Support Grant

$169,651
John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2023 · CA

(PQ5) Mitochondrial Transfer in Tumor Heterogeneity and Acquired Resistence to Therapy

$169,650
Michael A Teitell · University Of California Los Angeles · R21 · FY2019 · CA

Development of ESiPSC approach for non-germline GEM modeling

$169,626
Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive Immunotherapy

$169,597
Naoto Hirano · University Health Network · R01 · FY2011 · CA

Engineering Siglec15/TGF-beta targeted bispecific antibodies that modulate the tumor microenvironment and enhances T-cell immunotherapy against pancreatic cancer

$169,563
Samuel Lai · Univ Of North Carolina Chapel Hill · R21 · FY2024 · CA

Role of Bim and soluble B7-H1 in monitoring T cell responses to anti-PD-1 therapy in melanoma

$169,555
Haidong Dong · Mayo Clinic Rochester · R21 · FY2016 · CA

Core D: Animal Experimentation & Wound Healing

$169,530
Kevin D Cooper · Case Western Reserve University · P30 · FY2014 · AR

Harnessing oral acetate supplementation to enhance anti-tumor immunity

$169,500
Nicholas Collins · Weill Medical Coll Of Cornell Univ · R00 · FY2023 · CA

Development of a new treatment modality for melanoma brain metastases - Resubmission - 1

$169,500
Iman Osman · New York University School Of Medicine · R21 · FY2016 · CA

09-9: Detailed Reporting of Melanoma Incident Cases to Enhance Descriptive Epidem

$169,495
Dennis M. Deapen · University Of Southern California · N01 · FY2009 · CA

Likes Pins and Views: Engaging Moms on Teen Indoor Tanning Thru Social Media

$169,495
David B Buller · Klein Buendel, Inc. · R01 · FY2020 · CA

Targeting ERK5 for Colorectal Cancer Therapy

$169,469
Garth Powis · Phusis Therapeutics, Inc. · R21 · FY2021 · CA

Natural Product Antitumor Inducers of Apoptosis

$169,405
University Of California San Diego · R01 · FY2004 · CA

Slug Mediates the Acute Cutaneous Response to UVR

$169,400
Donna F Kusewitt · University Of Tx Md Anderson Can Ctr · R21 · FY2008 · AR

The germline variation in immune and epigenetic pathways and melanoma prognosis

$169,391
Tomas Kirchhoff · New York University School Of Medicine · R21 · FY2013 · CA

Induction of an Antitumor Immune Response in Patients with Melanoma

$169,328
Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA

Clinical Research

$169,315
Richard M Goldberg · Univ Of North Carolina Chapel Hill · P30 · FY2014 · CA

MATCHMAKERS - large-scale generation of reactive TCR-pMHC pairs from human NSCLC

$169,280
Sergio Quezada · University College London · OT2 · FY2024 · CA

Role of FAT1 somatic mutations in aggressiveness of head and neck cancer

$169,248
Yong Teng · Emory University · R03 · FY2022 · DE

Cancer Center Support Grant

$169,239
Steven D Leach · Dartmouth College · P30 · FY2020 · CA

Discovery of fused heterocyclic pyrazine based novel anti-mitotic agents for metastatic melanoma

$169,233
Souvik Banerjee · Middle Tennessee State University · R16 · FY2025 · GM